FINHUB Insights

TMO · Q3 FY25 · Jun 29 – Sep 27, 2025

Thermo Fisher Scientific Q3 FY25: where the revenue came from and where it went

Thermo Fisher Scientific Q3 FY25: revenue $11.1B (+5% year over year). Net profit $1.6B. Largest cohort Consumables $4.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jun 29 – Sep 27, 2025
Reported
Oct 31, 2025 10-Q
Sankey diagram of Thermo Fisher Scientific's income statement for Q3 FY25: revenue of $11.1 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$11.1B +5% year over year
Gross profit$4.3B 39% margin
Operating profit$1.9B 17% margin
Net profit$1.6B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 27, 2025).
ItemValueShare of revenueYear over year
Revenue 11.1 100% +5%
Consumables 4.7 42% +7%
Service 4.6 41% +4%
Instruments 1.8 16% +2%
Cost of revenue−6.861%
Gross profit4.339% margin−1pp
Research & development−0.33%+0pp
SG&A−2.119%+0pp
Operating profit1.917% margin+0pp
Tax−0.2
Interest & other costs−0.1
Net profit1.615%−1pp
Filing on EDGAR More quarters of TMO

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters